Course curriculum

    1. 13-valent pneumococcal (PCV13) vaccine in children (January 2020)

    2. Abnormal PTT (March 2022)

    3. Acute intermittent porphyria - 3Qs (November 2024)

    4. Allergic asthma and immunotherapy (May 2025)

    5. Allergic rhinitis - 3Qs (May 2024)

    6. Allergy testing - 2Qs (January 2025)

    7. Amyloidosis - 3Qs (May 2024)

    8. Anaphylaxis - 2Qs (January 2025)

    9. Androgenic alopecia (September 2024)

    10. Anemia in children - 5Qs (January 2024)

    11. Anemia of chronic disease (January 2025)

    12. Ankylosing spondylitis (September 2022)

    13. Antinuclear antibody testing (November 2024)

    14. Arthropod stings - 2Qs (May 2023)

    15. Antiphospholipid syndrome - 3Qs (May 2023)

    16. Atopic dermatitis - 3Qs (March 2020)

    17. Atopic dermatitis in children - 2Qs (March 2020)

    18. Atrial fibrillation and anticoagulation - 2Qs (March 2022)

    19. Autoimmune hemolytic anemia (September 2018)

    20. Autoimmune hepatitis - 2Qs

    21. Blood transfusions and COVID (March 2022)

    22. Celiac disease - 2Qs (May 2023)

    23. Celiac disease in adults - 3Qs (July 2024)

    24. Cervical adenopathy - 2Qs (March 2020)

    25. Chronic fatigue syndrome - 4Qs (March 2024)

    26. Chronic idiopathic urticaria (May 2023)

    27. Common variable immunodeficiency (March 2022)

    28. Cow's milk protein allergy - 3Qs (September 2024)

    29. Crohn's disease - 3Qs (March 2019)

    30. Dermatomyositis - 2Qs (January 2021)

    31. Discoid lupus (January 2023)

    32. Drug-induced angioedema - 2Qs (January 2019)

    33. Drug-induced lupus (March 2024)

    34. Eosinophilia (January 2024)

    35. Eosinophilia - 2Qs (May 2020)

    36. Erythema multiforme (November 2019)

    37. Erythropoietin stimulators - 2Qs (March 2025)

    38. Essential thrombocythemia - 2Qs (January 2024)

    39. Fish oil supplementation - 2Qs (November 2023)

    40. Graves disease (September 2018)

    41. Hemochromatosis - diagnosis (March 2024)

    42. Hemophilia - 3Qs (March 2022)

    43. Heparin-induced thrombocytopenia (November 2024)

    44. Hereditary spherocytosis - 3Qs (May 2022)

    45. Hoarseness - 2Qs (November 2022)

    46. HPV infection counseling (July 2022)

    47. Hypercoagulable state - 3Qs (November 2024)

    48. IgA deficiency - 3Qs (September 2024)

    49. IgA nephropathy - 2Qs (September 2019)

    50. IgA vasculitis - 3Qs (September 2024)

    51. Immune thrombocytopenia - 5Qs (March 2025)

    52. Immune thrombocytopenia (ITP) (September 2020)

    53. Immunization - Adult - 5Qs (November 2022)

    54. Immunizations and adults with HIV - 2Qs (September 2019)

    55. Immunizations and children with HIV (September 2019)

    56. Immunization of contacts of immunocompromised individuals (September 2020)

    57. Immunizations in those with immunosuppression - 2Qs (September 2020)

    58. Inferior vena cava filter - 2Qs (July 2022)

    59. Influenza vaccine - risks and benefits (September 2024)

    60. Iron deficiency in children - 3Qs (March 2025)

    61. Iron supplementation and premature infants (May 2025)

    62. Juvenile idiopathic arthritis - 2Qs (November 2023)

    63. Kawasaki disease (May 2019)

    64. Leukotriene receptor antagonists (May 2022)

    65. Leukotriene receptor antagonists - 2Qs (November 2018)

    66. Mastocytosis - 3Qs (January 2025)

    67. Mastocytosis (July 2022)

    68. Measles - 4Qs (November 2024)

    69. Measles (September 2020)

    70. Measles - 2Qs (November 2018)

    71. Meningococcal ACWY vaccines - 2Qs (November 2018)

    72. Meningococcal type B vaccine (November 2018)

    73. Montelukast - side effects (September 2020)

    74. Multiple sclerosis - treatment - 3Qs (September 2022)

    75. Oral allergy syndrome (May 2021)

    76. Peanut allergy (July 2024)

    77. Peanut allergy (March 2019)

    78. Peanut allergy prevention - 3Qs (September 2024)

    79. Peanut allergy - Reducing risk - 2Qs (November 2020)

    80. Pediatric celiac disease - 2Qs (May 2022)

    81. Penicillin allergy (September 2019)

    82. Pneumococcal disease - Prevention (July 2022)

    83. Pneumococcal vaccination update - 3Qs (November 2023)

    84. Pollen-food allergy syndrome (May 2022)

    85. Polyarteritis nodosa - 2Q (May 2025)

    86. Preventing atopic disease (September 2021)

    87. Psoriasis - 3Qs (September 2024)

    88. Psoriasis comorbidities - 2Qs (March 2019)

    89. Psoriatic arthritis (November 2019)

    90. Rapid-onset asthma - 3Qs (May 2025)

    91. Raynaud's phenomenon - 4Qs (July 2023)

    92. Reactions to contrast - 3Qs (November 2022)

    93. Reactions to contrast - 3Qs (July 2019)

    94. Reye syndrome - 2Qs (July 2023)

    95. Rheumatoid arthritis - lifestyle modifications (July 2024)

    96. Rh immunoglobulin - 3Qs (September 2022)

    97. Rheumatoid arthritis-associated lung disease (July 2019)

    98. Rotavirus (July 2022)

    99. Seasonal allergies - management - 2Qs (March 2023)

    100. Seborrheic dermatitis in infants (July 2023)

    101. Seborrheic dermatitis - overview - 2Qs (July 2023)

    102. Seborrheic dermatitis in skin of color (July 2023)

    103. Serogroup B meningococcal vaccine (July 2019)

    104. Sickle cell disease - screening (May 2025)

    105. Systemic juvenile idiopathic arthritis - 2Qs (May 2019)

    106. Systemic lupus erythematosis - 2Qs (March 2025)

    107. Systemic sclerosis - 3Qs (November 2024)

    108. Transfusion reactions - 3Qs (March 2019)

    109. Travel and polio - 2Qs (January 2020)

    110. Travel vaccinations during pregnancy and lactation (January 2020)

    111. Type 1 diabetes in children - health maintenance - 4Qs (November 2024)

    112. Uterine fibroids - 2Qs (March 2025)

    113. Vaccines and Medications That Affect Immunocompetence - 2Qs (November 2024)

    114. Varicella zoster vaccine (March 2023)

    115. Yellow fever - 2Qs (September 2019)

About this course

  • Free
  • 115 lessons
  • 0 hours of video content